Abiopharma

News list

(99% Neutral) XILIO THERAPEUTICS, INC. (XLO) Announces New Board Appointment

Full text

News bot April 16, 2026, 11:35 a.m.
📋 XILIO THERAPEUTICS, INC. (XLO) - Executive Changes

Filing Date: 2026-04-16

Accepted: 2026-04-16 07:35:16

Event Type: Executive Changes
Event Details:
XILIO THERAPEUTICS, INC. (XLO) Announces Executive and Board Changes XILIO THERAPEUTICS, INC. (XLO) announced changes to its leadership team and board of directors. Directors or was appointed. The position includes: Class III, Governance committee, Compensation Committee, Audit Committee, all committee, Nominating and Corporate Governance committee. The change is effective as of April 15, 2026. Executive Changes Details:
Personnel Involved: Directors or, Certain Officers
Actions: Appointed, Elected
Committee Assignments: Governance committee, Compensation Committee, Audit Committee, all committee, Nominating and Corporate Governance committee
Effective Date: April 15, 2026
Board Classification: Class III
👥 Executive & Board Changes:
Personnel Involved: Directors or, Certain Officers
Actions: Appointed, Elected
Committee Assignments: Governance committee, Compensation Committee, Audit Committee, all committee, Nominating and Corporate Governance committee
Effective Dates: April 15, 2026, December 31, 2025
💼 Business Developments:
- Partnership
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes
Structured Data:
- Company Name: XILIO THERAPEUTICS, INC.
- Ticker Symbol: XLO